2. According to ACIP and the CDC website, it is recommended that this patient receive the Prevnar 13 vaccine. Adults aged 65 years or older who have not received PCV13, but have received a dose of PPSV23 should be administered PCV13 at least 1 year after the dose of PPSV23.
3. According to Clinical Pharmacology, LexiComp, and Facts & Comparisons, this tablet is a Warfarin Sodium 3mg tablet and the manufacturer is Teva.
4. According to the …show more content…
Aydiner A, Ciftci R, Sen F. Renin-Angiotensin System Blockers May Prolong Survival of Metastatic Non-Small Cell Lung Cancer Patients Receiving Erlotinib. Medicine. 2015;94(22):e887. doi:10.1097/md.0000000000000887.
2. Dézsi C. A review of clinical studies on angiotensin II receptor blockers and risk of cancer. International Journal of Cardiology. 2014;177(3):748-753. doi:10.1016/j.ijcard.2014.11.031.
3. Waeber B, Wuerzner G, Burnier M. Critical review of cancer risk associated with angiotensin receptor blocker therapy. VHRM. 2011:741. doi:10.2147/vhrm.s13552.
4. Pasternak B, Svanstrom H, Callreus T, Melbye M, Hviid A. Use of Angiotensin Receptor Blockers and the Risk of Cancer. Circulation. 2011;123(16):1729-1736. doi:10.1161/circulationaha.110.007336.
5. Chiang Y, Chen K, Tsai T, Tsai W. Lowered Cancer Risk With ACE Inhibitors/ARBs: A Population-Based Cohort Study. J Clin Hypertens. 2013;16(1):27-33. doi:10.1111/jch.12228.
6. Bhaskaran K, Douglas I, Evans S, van Staa T, Smeeth L. Angiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK General Practice Research Database. BMJ. 2012;344(apr24 1):e2697-e2697.